Lifemd Inc (LFMD) Stock Price, Quote & News

Company Profile

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company operates through two operating segments: Telehealth and WorkSimpli. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs, including erectile dysfunction, premature ejaculation, and hair loss; ShapiroMD that provides vi...

Industry: Health Information Services

Sector: Healthcare

Phone: 866 351 5907

Website: lifemd.com

Address:

236 Fifth Avenue, Suite 400, New York, United States

SweepCastApp Oct. 4 at 10:12 AM

$LFMD: Unusual Options Activity Alerted CALL flow observed 299x contracts at Strike price of $7 Exp on 01/15/2027 with Premium of $60K and showing BEARISH Sentiment

0 · Reply

Alex1965 Oct. 3 at 10:22 PM

$LFMD Novo Nordisk to launch oral Wegovy weight loss pill on telehealth sites - report https://seekingalpha.com/news/4501764-novo-nordisk-launch-oral-wegovy-weight-loss-pill-telehealth-sites?mailingid=41847659&messageid=2900&serial=41847659.3733&source=email_2900&utm_campaign=rta-stock-news&utm_content=link-4&utm_medium=email&utm_source=seeking_alpha&utm_term=41847659.3733

0 · Reply

thejman1 Oct. 3 at 5:35 PM

$LFMD i would not be surprised if they cut back spending shifted some money and retained customers to make another profitable quarter show. last quarter was way below what it should have been. and the 1st quarter results shouldn't have shown a profit but they did. 4th quarter last year was bad. did they shifted things around then?

0 · Reply

InvertedThinking Oct. 3 at 2:52 PM

$LFMD

0 · Reply

Annaba514 Oct. 2 at 9:39 PM

$LFMD it seems No..

1 · Reply

Peteey Oct. 2 at 8:50 PM

$LFMD Send it to $20.

1 · Reply

MoonCowBoy Oct. 2 at 2:27 AM

Caught a few of @CarlosRivera_’s plays recently dude’s been on point! If you're into trading, he's worth a follow💯 watching $LFMD $SIRI $MRM $AMCR

0 · Reply

BillionerOfKing Oct. 1 at 3:47 PM

$LFMD Current Stock Price: $6.61 Contracts to trade: $5 LFMD Oct 17 2025 Call Entry: $1.55 Exit: $2.42 ROI: 56% Hold ~22 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

Alex1965 Oct. 1 at 1:15 PM

$LFMD The tariffs was all negotiations

0 · Reply

gmoney55 Oct. 1 at 12:48 PM

$LFMD shut down is going to hurt here... sold yesterday.

0 · Reply

LifeMD (LFMD) Faces Lawsuit Over Alleged Concealment of Cost and Refund Woes in Key Segments, According to Hagens Berman

Sep 30, 2025, 10:30 AM EDT - 4 days ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD

Sep 30, 2025, 8:14 AM EDT - 4 days ago

LifeMD to offer Novo's Ozempic at $499 per month to eligible US cash-paying customers

NVO

Sep 30, 2025, 8:00 AM EDT - 4 days ago

LifeMD Offers Ozempic® at $499 Per Month through Collaboration with Novo Nordisk

Sep 29, 2025, 3:44 PM EDT - 5 days ago

LifeMD (LFMD) Sued for Allegedly Misleading Investors on Growth Guidance According to Hagens Berman

Sep 26, 2025, 2:57 PM EDT - 8 days ago

Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements According to Hagens Berman

Sep 25, 2025, 4:06 PM EDT - 9 days ago

LifeMD to Participate in the ROTH 4th Annual Healthcare Opportunities Conference

LFMDP

Sep 24, 2025, 10:27 AM EDT - 10 days ago

LifeMD: Set To Ride A Telehealth Tailwind

Sep 23, 2025, 4:05 PM EDT - 11 days ago

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

LFMDP

Sep 22, 2025, 2:36 PM EDT - 12 days ago

Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements -- Hagens Berman

Sep 21, 2025, 7:49 AM EDT - 13 days ago

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD

Sep 18, 2025, 1:37 PM EDT - 16 days ago

LifeMD, Inc. Investors: Company Investigated by the Portnoy Law Firm

Sep 18, 2025, 8:00 AM EDT - 16 days ago

LifeMD Expands Pharmacy Services with Non-Sterile Compounding to Deliver Personalized, Cost-Efficient Therapies at Scale

LFMDP

Sep 17, 2025, 8:00 PM EDT - 16 days ago

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against LifeMD, Inc. (LFMD)

Sep 12, 2025, 12:11 PM EDT - 22 days ago

Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements – Hagens Berman

Sep 8, 2025, 4:38 PM EDT - 26 days ago

Shareholders who lost money in shares of LifeMD, Inc. (NASDAQ: LFMD) Should Contact Wolf Haldenstein Immediately

Sep 4, 2025, 11:51 AM EDT - 4 weeks ago

Berger Montague PC Investigates Securities Claims Against LifeMD, Inc. (NASDAQ: LFMD)

Aug 28, 2025, 8:00 AM EDT - 5 weeks ago

LifeMD to Participate in Three Investor Conferences During September

Aug 19, 2025, 6:11 AM EDT - 6 weeks ago

LifeMD: The Dip Could Deepen, Valuation More Attractive

Aug 16, 2025, 6:16 PM EDT - 7 weeks ago

LFMD Investors Have Opportunity to Join LifeMD, Inc. Fraud Investigation with the Schall Law Firm

Aug 5, 2025, 7:51 PM EDT - 2 months ago

LifeMD, Inc. (LFMD) Q2 2025 Earnings Call Transcript

LFMDP

Aug 5, 2025, 4:05 PM EDT - 2 months ago

LifeMD Reports Second Quarter 2025 Results

Aug 4, 2025, 4:05 PM EDT - 2 months ago

Medifast Announces Second Quarter 2025 Financial Results

MED

Aug 4, 2025, 8:00 AM EDT - 2 months ago

LifeMD to Participate in the Canaccord Genuity 45th Annual Growth Conference

LFMDP

Jul 31, 2025, 8:00 AM EDT - 2 months ago

LifeMD Names COO and Promotes Two Executives

Jun 26, 2025, 5:21 AM EDT - 3 months ago

LifeMD: Inflection Into Profitability Should Drive Stock Upward

Jun 25, 2025, 3:02 AM EDT - 3 months ago

LifeMD: An Overlooked GLP-1 Beneficiary

Jun 9, 2025, 8:00 AM EDT - 4 months ago

LifeMD to Participate in Two Investor Conferences During June

Jun 4, 2025, 2:12 PM EDT - 4 months ago

LifeMD: Growth, Growth, And More Growth

May 23, 2025, 9:16 AM EDT - 4 months ago

Top 2 Health Care Stocks That May Implode In Q2

HAFN

May 22, 2025, 8:05 AM EDT - 4 months ago

LifeMD Collaborates with Novo Nordisk to Launch $299 Introductory Bundle for Self-Pay Patients Prescribed Wegovy®

LFMDP

May 12, 2025, 4:05 PM EDT - 5 months ago

LifeMD to Participate in Three Investor Conferences During May

LFMDP

May 6, 2025, 6:47 PM EDT - 5 months ago

LifeMD, Inc. (LFMD) Q1 2025 Earnings Call Transcript

LFMDP

May 6, 2025, 4:05 PM EDT - 5 months ago

LifeMD Reports First Quarter 2025 Results and Raises Full-Year 2025 Guidance

Apr 29, 2025, 8:05 AM EDT - 5 months ago

LifeMD Announces Plans to Expand Affordable Access to Wegovy® for Cash-Pay Patients

LFMDP

Apr 28, 2025, 4:05 PM EDT - 5 months ago

LifeMD to Report First Quarter 2025 Financial Results on May 6

LFMDP

SweepCastApp Oct. 4 at 10:12 AM

$LFMD: Unusual Options Activity Alerted CALL flow observed 299x contracts at Strike price of $7 Exp on 01/15/2027 with Premium of $60K and showing BEARISH Sentiment

0 · Reply

Alex1965 Oct. 3 at 10:22 PM

0 · Reply

thejman1 Oct. 3 at 5:35 PM

0 · Reply

InvertedThinking Oct. 3 at 2:52 PM

$LFMD

0 · Reply

Annaba514 Oct. 2 at 9:39 PM

$LFMD it seems No..

1 · Reply

Peteey Oct. 2 at 8:50 PM

$LFMD Send it to $20.

1 · Reply

MoonCowBoy Oct. 2 at 2:27 AM

Caught a few of @CarlosRivera_’s plays recently dude’s been on point! If you're into trading, he's worth a follow💯 watching $LFMD $SIRI $MRM $AMCR

0 · Reply

BillionerOfKing Oct. 1 at 3:47 PM

0 · Reply

Alex1965 Oct. 1 at 1:15 PM

$LFMD The tariffs was all negotiations

0 · Reply

gmoney55 Oct. 1 at 12:48 PM

$LFMD shut down is going to hurt here... sold yesterday.

0 · Reply

DaBullRunner Sep. 30 at 11:53 PM

$LFMD let’s get it…. ICU is going to make a big run soon 🚨🚨🚨🚨🚨 Here’s why👇

0 · Reply

LiquidThetaLEAPS Sep. 30 at 11:00 PM

LiquidTheta® LEAPS LIVE Actionable Alert Asset: $LFMD Current Share Price: $6.43 Contracts: $LFMD January 15, 2027 $7 Calls Scale in: $1.75- $2.14 Scale out: $2.73-$3.51 Can Easily Capture: 60% ROI Blended DTE: 473 Days | Join Elites here: https://liquidtheta.com/options

0 · Reply

Finanz Sep. 30 at 9:39 PM

$LFMD Chart is looking...like...it could breakout.

0 · Reply

thejman1 Sep. 30 at 8:35 PM

$LFMD these are the new costs for everyone selling it. as posted back in April. some starter shots are even 350 a . desperate news. equals no gains.

0 · Reply

thejman1 Sep. 30 at 5:22 PM

$LFMD other companies still selling compounded for 200. people want the cheapest not the name brand.

0 · Reply

Wildfire_32 Sep. 30 at 2:47 PM

$LFMD Thank you to the market maker who filled that gap up this morning. Fintel has institutional ownership up to 60% as of august with insiders around 25%. Hopefully we can continue the climb and the company keeps giving the market a reason to

0 · Reply

Annaba514 Sep. 30 at 1:56 PM

$LFMD why not +25% today ??

0 · Reply

StocktwitsNews Sep. 30 at 12:50 PM

LifeMD Offers Novo Nordisk’s Ozempic For $499 A Month To Eligible Patients $LFMD $NVO https://stocktwits.com/news/equity/markets/lifemd-novo-nordisk-ozempic-499-a-month/chDD7hZR3Br

0 · Reply

Jigalu Sep. 30 at 12:30 PM

$LFMD the stock is so dead, a news like this would have sent us +10-15% in april lol

0 · Reply

DonCorleone77 Sep. 30 at 12:08 PM

$LFMD $NVO LifeMD offers Ozempic at $499 per month via Novo Nordisk collaboration

2 · Reply

highnihilism Sep. 30 at 9:50 AM

$LFMD Lifemd: 211 trades, $68K vs $224K avg (0.30x !!). $47K calls / $20K puts. $BRKR Bruker: 139 trades, $89K vs $116K avg (0.76x). $47K calls / $41K puts. $MEOH Methanex: 27 trades, $49K vs $29K avg (1.70x). $47K calls / $3K puts. $IQ Iqiyi: 311 trades, $50K vs $359K avg (0.14x !!!). $47K calls / $3K puts.

0 · Reply

Leroy_Jankins Sep. 29 at 3:11 PM

$LFMD these guys need to have an investor day presentation and show their projected Revenue and EBITDA by 2030 the way HIMS did. Their ER left a lot of unanswered questions about their ability to grow in spite of refunds/churn and addressing those concerns is going to be essential to get back to $12+

1 · Reply

Market Cap	328.13M
Revenue (ttm)	212.45M
Net Income (ttm)	-18.88M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-8.89%
Debt to Equity Ratio	40.74

Volume	1,447,700
Avg Vol	1,812,718
Day's Range	N/A - N/A
Shares Out	47.42M
Stochastic %K	72%
Beta	1.67
Analysts	Strong Sell
Price Target	$13.14